Neumora Therapeutics, Inc. Common Stock

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Rok finansowy 2020 2021 2021 2021 2021 2022 2022 2022 2022 2023 2023 2023 2023 2024 2024 2024 2024 2025
Kwartał Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1
Data 2020-12-31 2021-03-31 2021-06-30 2021-09-30 2021-12-31 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30 2024-12-31 2025-03-31
Przychód (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Przychód Δ kw/kw 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto 0.0% -inf% 0.0% 0.0% 0.0% -inf% -inf% -inf% -inf% -inf% -inf% -inf% -inf% -inf% -inf% 0.0% 0.0% 0.0%
Koszty i Wydatki (mln) 20 15 17 178 27 43 31 31 31 39 42 57 114 60 64 77 63 0
EBIT (mln) -20 -15 -17 -178 -27 -43 -31 -31 -31 -39 -42 -57 -114 -60 -64 -77 -63 -71
EBIT Δ kw/kw 0.0% 0.0% 0.0% 0.0% 35.9% 179.9% 82.1% -82.82% 15.7% -9.41% 34.3% 85.8% 271.1% 53.4% 51.7% 34.8% -44.81% 18.1%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan nan
Przychody fiansowe (mln) 0 0 0 0 0 0 1 1 2 4 4 4 6 6 5 4 4 3
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Amortyzacja (mln) 0 0 0 0 0 0 0 1 1 1 1 1 0 0 0 0 0 0
EBITDA (mln) -19 -15 -17 -178 -26 -43 -31 -30 -30 -38 -41 -56 -100 -60 -64 -76 -63 -71
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan nan
NOPLAT (mln) -20 -15 -17 -178 -27 -43 -30 -29 -28 -36 -39 -53 -108 -54 -59 -72 -59 -68
Podatek (mln) 0 -0 0 0 0 -0 -1 -1 -2 -4 -4 -4 -5 -6 0 0 0 0
Zysk Netto (mln) -20 -15 -17 -178 -27 -43 -30 -29 -28 -36 -39 -53 -109 -54 -59 -73 -59 -68
Zysk netto Δ kw/kw 0.0% 0.0% 0.0% 0.0% 34.9% 181.2% 78.5% -83.52% 4.4% -17.23% 26.9% 80.7% 286.3% 50.8% 52.3% 36.8% -45.90% 26.6%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan nan
EPS -0.13 -0.1 -0.11 -1.17 -0.18 -0.28 -0.2 -0.19 -0.19 -0.23 -0.25 -0.34 -0.68 -0.34 -0.37 -0.45 -0.37 -0.42
EPS (rozwodnione) -0.13 -0.1 -0.11 -1.17 -0.18 -0.28 -0.2 -0.19 -0.19 -0.23 -0.25 -0.34 -0.68 -0.34 -0.37 -0.45 -0.37 -0.42
Ilośc akcji (mln) 152 152 152 152 152 152 152 152 152 152 152 155 159 158 159 160 161 161
Ważona ilośc akcji (mln) 152 152 152 152 152 152 152 152 152 152 152 155 159 158 159 160 161 161
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD